UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SP0239 Juvenile Systemic Sclerosis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.58-58

Foeldvari, I.

2015

Volltextzugriff (PDF)

AB0686 Results of the multinational e-mail survey regarding follow up of patients with l raynaud’s phenomenon

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A997-A998

Foeldvari, I.

2013

Volltextzugriff (PDF)

AB1164 Results of the multinational e-mail survey regarding follow up of patients with localised scleroderma and raynaud’s phenomenon

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.704-704

Foeldvari, I.

2013

Volltextzugriff (PDF)

FRI0349 Results of a multinational survey regarding the definition of remission in juvenile idiopathic arthritis related uveitis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.432-432

Foeldvari, I.

2013

Volltextzugriff (PDF)

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

Annals of the rheumatic diseases, 2009-04, Vol.68 (4), p.519-525

2009

Volltextzugriff (PDF)

Temporomandibular joint involvement in patients with juvenile idiopathic arthritis: a retrospective chart review

Scandinavian journal of rheumatology, 2020-07, Vol.49 (4), p.271-280

2020

Volltextzugriff (PDF)

Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry

Arthritis care & research (2010), 2012-09, Vol.64 (9), p.1349-1356

2012

Volltextzugriff (PDF)

THU0561 Anakinra first- or second-line in systemic juvenile idiopathic arthritis patients

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.482

2018

Volltextzugriff (PDF)

POS1301 DRUG SURVIVAL OF BIOLOGICS WITH RESPECT TO COMBINATION WITH METHOTREXATE IN TREATMENT OF POLYARTICULAR JIA

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.932-933

2021

Volltextzugriff (PDF)

FRI0506 High Prevalence of Extracutaneous Manifestations and Comorbidities in 108 Patients with Juvenile Localized Scleroderma

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.612-612

2015

Volltextzugriff (PDF)

Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis

Seminars in arthritis and rheumatism, 2019-08, Vol.49 (1), p.43-55

2019

Volltextzugriff (PDF)

Durometry as an outcome measure in juvenile localized scleroderma

British journal of dermatology (1951), 2016-01, Vol.174 (1), p.228-230

2016

Volltextzugriff (PDF)

Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry

Pediatric rheumatology online journal, 2021-03, Vol.19 (1), p.41-41, Article 41

2021

Volltextzugriff (PDF)

POS1379 LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.971-972

2021

Volltextzugriff (PDF)

OP0092 LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) – 30-MONTH DATA FROM THE RELIANCE REGISTRY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.50-51

2021

Volltextzugriff (PDF)

POS1325 COMPARISON OF THREE DIFFERENT ALGORITHMS FOR THE TREATMENT OF CHILDREN WITH POLYARTICULAR JIA: THE FIRST YEAR AFTER DIAGNOSIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.945-945

2021

Volltextzugriff (PDF)

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes

Journal of the European Academy of Dermatology and Venereology, 2024-07, Vol.38 (7), p.1251-1280

2024

Volltextzugriff (PDF)

Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry

Scandinavian journal of rheumatology, 2019-03, Vol.48 (2), p.95-104

2019

Volltextzugriff (PDF)

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

Annals of the rheumatic diseases, 2010-04, Vol.69 (4), p.718-722

2010

Volltextzugriff (PDF)

SAT0510 LONG-TERM EFFECTIVENESS OF CANAKINUMAB IN AID – INTERIM ANALYSIS OF THE CAPS SUBGROUP FROM THE RELIANCE REGISTRY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1211-1211

2020

Volltextzugriff (PDF)

Skin involvement in systemic sclerosis

Rheumatology (Oxford, England), 2008-10, Vol.47 (suppl-5), p.v44-v45

2008

Volltextzugriff (PDF)

Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study

Rheumatology (Oxford, England), 2006-05, Vol.45 (5), p.614-620

2006

Volltextzugriff (PDF)

POS0763 AN EVALUATION OF THE EFFICIENCY OF METHOTREXATE IN THE TREATMENT OF JUVENILE ENTHESITIS RELATED ARTHRITIS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.673-673

2023

Volltextzugriff (PDF)

AB0685 Results for 6 minute walk values in healthy german children show similar results as from britain

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A997-A997

2013

Volltextzugriff (PDF)

LB0004 EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.201-202

2021

Volltextzugriff (PDF)

1 – 25 von 504

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(461)
Mit Volltextzugriff
(342)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(252)
Life Sciences & Biomedicine
(239)
Rheumatology
(187)
Humans
(178)
Child
(110)
Female
(94)
Male
(90)
Adolescent
(81)
Arthritis
(75)
Patients
(74)
Pediatrics
(70)
Treatment Outcome
(53)
Arthritis, Juvenile - Drug Therapy
(51)
Child, Preschool
(50)
Biological And Medical Sciences
(45)
Medical Sciences
(43)
Juvenile Idiopathic Arthritis
(42)
Scleroderma
(40)
Diseases Of The Osteoarticular System
(37)
Systemic Sclerosis
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

SP0239 Juvenile Systemic Sclerosis

AB0686 Results of the multinational e-mail survey regarding follow up of patients with l raynaud’s phenomenon

AB1164 Results of the multinational e-mail survey regarding follow up of patients with localised scleroderma and raynaud’s phenomenon

FRI0349 Results of a multinational survey regarding the definition of remission in juvenile idiopathic arthritis related uveitis

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

Temporomandibular joint involvement in patients with juvenile idiopathic arthritis: a retrospective chart review

Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry

THU0561 Anakinra first- or second-line in systemic juvenile idiopathic arthritis patients

POS1301 DRUG SURVIVAL OF BIOLOGICS WITH RESPECT TO COMBINATION WITH METHOTREXATE IN TREATMENT OF POLYARTICULAR JIA

FRI0506 High Prevalence of Extracutaneous Manifestations and Comorbidities in 108 Patients with Juvenile Localized Scleroderma

Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis

Durometry as an outcome measure in juvenile localized scleroderma

Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry

POS1379 LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY

OP0092 LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) – 30-MONTH DATA FROM THE RELIANCE REGISTRY

POS1325 COMPARISON OF THREE DIFFERENT ALGORITHMS FOR THE TREATMENT OF CHILDREN WITH POLYARTICULAR JIA: THE FIRST YEAR AFTER DIAGNOSIS

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes

Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

SAT0510 LONG-TERM EFFECTIVENESS OF CANAKINUMAB IN AID – INTERIM ANALYSIS OF THE CAPS SUBGROUP FROM THE RELIANCE REGISTRY

Skin involvement in systemic sclerosis

Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study

POS0763 AN EVALUATION OF THE EFFICIENCY OF METHOTREXATE IN THE TREATMENT OF JUVENILE ENTHESITIS RELATED ARTHRITIS

AB0685 Results for 6 minute walk values in healthy german children show similar results as from britain

LB0004 EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)

Suchergebnisse filtern